CRWV:NASDAQCoreWeave, Inc. Analysis
Data as of 2026-09-28 - not real-time
$84.25
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind CoreWeave, Inc. is neutral at $84.25, with no clear ordering between short and long averages. It has lost 20.0% over the past 30 days. Relative strength is 46.9 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $78.27 and resistance at $104.59.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 68.0% above where the shares trade now. Revenue is growing at 112.5% on a -25.4% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 71.1%, a beta of 3.25 and a maximum drawdown of 57.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 4/10 long-term conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 68.0% above where the shares trade now. Revenue is growing at 112.5% on a -25.4% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 71.1%, a beta of 3.25 and a maximum drawdown of 57.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 4/10 long-term conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 92.15
- MACD momentum is positive
- 30-day price change of -20.0%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 92.15
- Analyst targets imply +68.0% versus the current price
- 30-day volatility of 71.1%
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative profit margin of -25.4%
- Analyst targets imply +68.0% versus the current price
- Negative return on equity of -43.6%
Key Metrics & Analysis
Financial Health
Revenue Growth112.50%
Profit Margin-25.40%
P/E Ratio-46.2
ROE-43.60%
ROA-0.24%
Debt/Equity1027.33
P/B Ratio9.2
Op. Cash Flow$6.9B
Free Cash Flow$-9088615424
Industry P/E34.3
Technical Analysis
TrendNeutral
RSI46.9
Support$78.27
Resistance$104.59
MA 20$86.20
MA 50$85.98
MA 200$92.15
MACDBullish
VolumeIncreasing
Fear & Greed Index92.52
Valuation
Fair Value$201.55
Target Price$141.58
Upside/Downside68.05%
GradeFair
TypeGrowth
Risk Assessment
Beta3.25
Volatility71.15%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.